NasdaqGS - Nasdaq Real Time Price • USD
Evotec SE (EVO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:44 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 3 | 3 |
| Avg. Estimate | -0.03 | -0.04 | -0.35 | 0.11 |
| Low Estimate | -0.07 | -0.04 | -0.48 | 0.1 |
| High Estimate | 0.01 | -0.04 | -0.16 | 0.13 |
| Year Ago EPS | -0.08 | -0.04 | -0.52 | -0.35 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 4 | 4 |
| Avg. Estimate | 219.73M | 231.1M | 816.87M | 965.99M |
| Low Estimate | 219.72M | 231.1M | 776.93M | 876.92M |
| High Estimate | 219.73M | 231.1M | 841.83M | 1.01B |
| Year Ago Sales | 245.69M | 229.12M | 789.38M | 816.87M |
| Sales Growth (year/est) | -10.60% | 0.90% | 3.50% | 18.30% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | 0.1 | 0.11 | -0.04 | -0.05 |
| EPS Actual | -0.08 | -0.04 | -0.04 | -0.12 |
| Difference | -0.18 | -0.15 | 0 | -0.07 |
| Surprise % | -180.00% | -136.40% | 0.00% | -140.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.04 | -0.35 | 0.11 |
| 7 Days Ago | -0.03 | -0.04 | -0.35 | 0.11 |
| 30 Days Ago | -0.03 | -0.04 | -0.35 | 0.12 |
| 60 Days Ago | -0.03 | -0.04 | -0.35 | 0.12 |
| 90 Days Ago | -0.03 | -0.04 | -0.35 | 0.17 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EVO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 62.50% | -- | -- | 1.50% |
| Next Qtr. | 0.00% | -- | -- | 11.40% |
| Current Year | 32.70% | -- | -- | 5.20% |
| Next Year | 131.40% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 235.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/31/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/12/2023 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 6/23/2023 |
| Downgrade | B of A Securities: Buy to Neutral | 6/16/2023 |
| Upgrade | Citigroup: Neutral to Buy | 6/8/2023 |
| Upgrade | Morgan Stanley: Underweight to Equal-Weight | 4/4/2023 |
Related Tickers
AMRX Amneal Pharmaceuticals, Inc.
6.05
+12.04%
KMDA Kamada Ltd.
5.18
+1.57%
LFCR Lifecore Biomedical, Inc.
6.33
-1.86%
ALKS Alkermes plc
24.65
+1.61%
HCM HUTCHMED (China) Limited
18.41
+0.88%
MEDXF Medexus Pharmaceuticals Inc.
1.3000
+7.00%
INDV Indivior PLC
18.81
+0.97%
ROMJF Rubicon Organics Inc.
0.2661
-1.17%
ALVO Alvotech
13.54
+1.04%
BFRI Biofrontera Inc.
1.6600
+10.67%